Want to see DE:93M1 full AI Analyst Report?
93M1 Stock Chart & Stats
€22.10
€0.00(0.00%)
At close: 4:00 PM EST
€22.10
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€16.85 - €29.50
Previous CloseN/A
Volume851.00
Average Volume (3M)1.46K
Market Cap
€126.30M
Enterprise Value€134.00M
Total Cash (Recent Filing)€1.37M
Total Debt (Recent Filing)€11.63M
Price to Earnings (P/E)4.3
Beta0.38
Next Earnings
Sep 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.31%
Share Statistics
EPS (TTM)6.85
Shares Outstanding4,281,384
10 Day Avg. Volume2,127
30 Day Avg. Volume1,460
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.39
Price to Sales (P/S)0.26
P/FCF Ratio765.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)5.9
Revenue Forecast (FY)€29.12M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage (debt-to-equity ~2%–6%) gives durable financial flexibility. Over 2–6 months this reduces refinancing risk, supports funding for portfolio companies or opportunistic acquisitions, and cushions earnings swings from portfolio valuation moves.
Holding-company ModelAs an investment holding focused on healthcare, revenue sources include dividends, sale gains and fair-value changes. This diversified return mix provides structural optionality to monetize assets, shift allocations and capture sector consolidation over the medium term.
Return To Sustained ProfitabilityConsistent positive earnings since 2022 and ~8% net margin in 2025 indicate the group can generate recurring profits. For a holding vehicle, sustained profitability supports distributions, retained capital for reinvestment and credibility with partners and lenders.
Bears Say
Weak, Volatile Cash FlowHighly inconsistent operating and free cash flow undermines the company’s ability to self-fund investments or pay stable dividends. Over the medium term this increases reliance on asset sales or external financing and raises execution risk for portfolio support.
Erratic Revenue TrendsA large recent decline in reported revenue and historically erratic top-line patterns signal low predictability of cash returns from portfolio operations. This reduces visibility into future earnings and complicates planning for reinvestment or distributions.
Earnings Quality / Equity ErosionDeclining equity and hints of valuation or distribution-driven movements imply profitability may rely on non-operating gains. Structural dependence on fair-value swings or disposals weakens earnings quality and can limit capital available for strategic initiatives.
93M1 FAQ
What was MPH Health Care AG’s price range in the past 12 months?
MPH Health Care AG lowest stock price was €16.85 and its highest was €29.50 in the past 12 months.
What is MPH Health Care AG’s market cap?
MPH Health Care AG’s market cap is €126.30M.
When is MPH Health Care AG’s upcoming earnings report date?
MPH Health Care AG’s upcoming earnings report date is Sep 16, 2026 which is in 77 days.
How were MPH Health Care AG’s earnings last quarter?
Currently, no data Available
Is MPH Health Care AG overvalued?
According to Wall Street analysts MPH Health Care AG’s price is currently Overvalued.
Does MPH Health Care AG pay dividends?
MPH Health Care AG pays a Annually dividend of €4.999 which represents an annual dividend yield of 5.31%. See more information on MPH Health Care AG dividends here
What is MPH Health Care AG’s EPS estimate?
MPH Health Care AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MPH Health Care AG have?
MPH Health Care AG has 4,281,384 shares outstanding.
What happened to MPH Health Care AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MPH Health Care AG?
Currently, no hedge funds are holding shares in DE:93M1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MPH Health Care AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.52%
12-Months-Change
Fundamentals
Return on Equity
12.13%
Trailing 12-Months
Asset Growth
-11.33%
Trailing 12-Months
Company Description
MPH Health Care AG
MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and various other chronic conditions. Beyond pharmaceuticals, it also delivers medical aesthetic treatments, develops and markets a diverse array of pharmaceutical and medical items, and furnishes related services and specialized medical devices for use in aesthetic surgery and cosmetic dermatology. Furthermore, its operations extend to supplying cytostatic solutions and involvement in real estate ventures. Established in Berlin in 2008, the company adopted its current name, MPH Health Care AG, in 2017, having previously been known as MPH Mittelständische Pharma Holding AG. It functions as a subsidiary of Magnum AG.
Technical Analysis
Options Prices
Currently, No data available
---